Radiology and Oncology (Mar 2020)
Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer
Abstract
Esophageal cancer remains a disease with poor survival and many complications. Measuring muscle mass and quality can identify patients with diminished muscle mass (sarcopenia) and muscle fat infiltration (myosteatosis). We studied the impact of sarcopenia and myosteatosis in resectable esophageal cancer on overall survival and complications.
Keywords